Rep. Angie Craig Introduces Bill Ensuring Equitable Covid-19 Vaccine Distribution

Press Release

Date: Oct. 9, 2020
Location: Washington, DC

Today, U.S. Rep Angie Craig announced the introduction of new legislation aimed to ensure that an eventual COVID-19 vaccine is equitably allocated and distributed. The COVID-19 Vaccine Fairness Act would direct the Administration to develop a plan to provide states with the resources and direction needed to effectively administer the vaccine. A thorough and transparent strategy is needed to make sure no American is left behind. Rep. Craig has repeatedly called for national testing and supply chain strategies and this proposal is a continuation of her efforts to combat the spread of COVID-19.

"A coordinated strategy between the federal government and states is critical to a successful and fair vaccine distribution," said Rep. Craig. "As COVID-19 vaccine development progresses, the Administration must adopt a transparent plan that includes regular public updates to ensure that the vaccine is equitably distributed. The legislation I've put forward will require the Administration to be prepared with a detailed, transparent plan for vaccine distribution."

The COVID-19 Vaccine Fairness Act would direct the Department of Health and Human Services to provide weekly updates on the Administration's efforts to ensure a transparent and equitable vaccine distribution process, including:

The number of the vaccines distributed and administered
Measures to ensure the vaccine reaches those groups particularly at risk for complications and transmission in accordance with the National Academies of Sciences, Engineering, and Medicine
Any bottlenecks in the supply chain, including obstacles reaching state, local, territorial, and tribal health departments, high-risk facilities such as long-term care facilities, and tracking
Progress reports on outreach to the public about vaccine availability, safety, benefits, and contraindications
Efforts to update health care providers and facilities on their responsibilities regarding vaccine tracking and adverse event monitoring


Source
arrow_upward